Sotera Health (SHC)
(Real Time Quote from BATS)
$14.18 USD
+0.96 (7.26%)
Updated Aug 5, 2024 02:30 PM ET
2-Buy of 5 2
B Value B Growth B Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SHC 14.18 +0.96(7.26%)
Will SHC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SHC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SHC
Compared to Estimates, Sotera Health (SHC) Q2 Earnings: A Look at Key Metrics
Sotera Health Company (SHC) Q2 Earnings and Revenues Surpass Estimates
SHC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Establishment Labs (ESTA) Surges 7.4%: Is This an Indication of Further Gains?
Sotera Health Company (SHC) Misses Q1 Earnings and Revenue Estimates
Sotera Health Company (SHC) Reports Next Week: Wall Street Expects Earnings Growth
Other News for SHC
Dow Tumbles 950 Points; ISM Services PMI Surges In July
Buffett cuts Apple, Tyson reports Q3 beat: Morning Buzz
Sotera Health Posts Upbeat Results, Joins Thoughtworks, Sonic Automotive And Other Big Stocks Moving Higher On Monday
What's Driving Sotera Health Co's Surprising 21% Stock Rally?
Sotera Health Reports Second-Quarter and First-Half 2024 Results